Abstract
The present disclosure relates to antisense oligomers targeting the long non-coding RNA HOXB-AS3 and methods of treating acute myeloid leukemia.
Originalsprog | Engelsk |
---|---|
IPC | C12N 15/ 113 A I |
Patentnummer | WO2018085656 |
Journaliseringsdato | 11/05/2018 |
Land/Område | Danmark |
Prioritetsdato | 03/11/2016 |
Prioritetsnummer | US201662416993P |
Status | Udgivet - 2018 |